Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals - PubMed (original) (raw)
Comparative Study
Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals
M L Cunningham et al. Eur J Biochem. 1994.
Free article
Abstract
The dithiol trypanothione, novel to trypanosomatids and analogous to glutathione in mammalian systems, has been shown to interact with anti-trypanocidal trivalent arsenical drugs forming a stable adduct, MelT. This adduct is a competitive inhibitor of the flavoprotein trypanothione reductase, responsible for maintaining intracellular trypanothione in the reduced form. Since trypanothione reductase and the analogous glutathione reductase both contain catalytically active sulphydryl groups we have examined the ability of several arsenicals to differentially inhibit these enzymes. Melarsen oxide [p-(4,6-diamino-s-triazin-2-yl)aminophenylarsenoxide] potently inhibits both enzymes in two stages, the first being essentially complete within 1 min, the second being time dependent, exhibiting saturable pseudo-first-order kinetics with kinact of 14.3 x 10(-4) s-1 and 1.06 x 10(-4) s-1 and Ki of 17.2 microM and 9.6 microM for trypanothione reductase and glutathione reductase, respectively. Inhibition requires prior reduction of the enzyme by NADPH and can be reversed by excess dithiols or prevented by MelT in the case of trypanothione reductase. In both cases a time-dependent loss of the characteristic charge-transfer absorbance band at 530 nm is observed upon addition of arsenical to pre-reduced enzyme, which with excess NADPH leads to a spectrum resembling the EH4 form and is accompanied by an increased ability to reduce molecular oxygen. A model for inhibition is proposed where, first, free arsenical and previously reduced enzyme immediately establish an equilibrium with an inactive monothioarsane enzyme-inhibitor complex involving the interchange cysteine distal to the FAD; second, a subsequent rearrangement about the sulphur-arsenic bond leads to the binding of the arsenical to the charge-transfer cysteine, proximal to the FAD, forming a more stable dithioarsane complex. Molecular modelling suggests that the differences in kinetic behaviour of the two enzymes can be attributed to structural features of their respective disulphide-binding sites. Incubation of reduced trypanothione reductase with excess dihydrotrypanothione and melarsen oxide prevents direct inhibition of the enzyme, suggesting that dihydrotrypanothione acts as a protectant in vivo, preventing the direct modification of trypanothione reductase by sequestering the arsenical as MelT.
Similar articles
- Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials.
Cunningham ML, Fairlamb AH. Cunningham ML, et al. Eur J Biochem. 1995 Jun 1;230(2):460-8. doi: 10.1111/j.1432-1033.1995.tb20583.x. Eur J Biochem. 1995. PMID: 7607216 - Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
Fairlamb AH, Carter NS, Cunningham M, Smith K. Fairlamb AH, et al. Mol Biochem Parasitol. 1992 Jul;53(1-2):213-22. doi: 10.1016/0166-6851(92)90023-d. Mol Biochem Parasitol. 1992. PMID: 1501641 - Trypanothione is the primary target for arsenical drugs against African trypanosomes.
Fairlamb AH, Henderson GB, Cerami A. Fairlamb AH, et al. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2607-11. doi: 10.1073/pnas.86.8.2607. Proc Natl Acad Sci U S A. 1989. PMID: 2704738 Free PMC article. - Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development.
Schmidt A, Krauth-Siegel RL. Schmidt A, et al. Curr Top Med Chem. 2002 Nov;2(11):1239-59. doi: 10.2174/1568026023393048. Curr Top Med Chem. 2002. PMID: 12171583 Review. - Metabolism and functions of trypanothione in the Kinetoplastida.
Fairlamb AH, Cerami A. Fairlamb AH, et al. Annu Rev Microbiol. 1992;46:695-729. doi: 10.1146/annurev.mi.46.100192.003403. Annu Rev Microbiol. 1992. PMID: 1444271 Review.
Cited by
- Interplay between the oxidation process and cytotoxic effects of antimonene nanomaterials.
Congost-Escoin P, Lucherelli MA, Oestreicher V, García-Lainez G, Alcaraz M, Mizrahi M, Varela M, Andreu I, Abellán G. Congost-Escoin P, et al. Nanoscale. 2024 May 23;16(20):9754-9769. doi: 10.1039/d4nr00532e. Nanoscale. 2024. PMID: 38625086 Free PMC article. - Arsenic in medicine: past, present and future.
Paul NP, Galván AE, Yoshinaga-Sakurai K, Rosen BP, Yoshinaga M. Paul NP, et al. Biometals. 2023 Apr;36(2):283-301. doi: 10.1007/s10534-022-00371-y. Epub 2022 Feb 21. Biometals. 2023. PMID: 35190937 Free PMC article. Review. - Trypanothione Reductase Gene Mutations in Meglumine Antimoniate Resistant Isolates from Cutaneous Leishmaniasis Patients Using Molecular Dynamics Method.
Fozongari F, Dalimi A, Arab SS, Behmanesh M, Khammari A. Fozongari F, et al. Iran J Parasitol. 2020 Oct-Dec;15(4):511-520. doi: 10.18502/ijpa.v15i4.4856. Iran J Parasitol. 2020. PMID: 33884008 Free PMC article. - Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies.
Matadamas-Martínez F, Hernández-Campos A, Téllez-Valencia A, Vázquez-Raygoza A, Comparán-Alarcón S, Yépez-Mulia L, Castillo R. Matadamas-Martínez F, et al. Molecules. 2019 Sep 4;24(18):3216. doi: 10.3390/molecules24183216. Molecules. 2019. PMID: 31487860 Free PMC article. - A glutaredoxin in the mitochondrial intermembrane space has stage-specific functions in the thermo-tolerance and proliferation of African trypanosomes.
Ebersoll S, Musunda B, Schmenger T, Dirdjaja N, Bonilla M, Manta B, Ulrich K, Comini MA, Krauth-Siegel RL. Ebersoll S, et al. Redox Biol. 2018 May;15:532-547. doi: 10.1016/j.redox.2018.01.011. Epub 2018 Jan 31. Redox Biol. 2018. PMID: 29413965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources